[1]
|
MCBRIDE A A. Human papillomaviruses:diversity, infection and host interactions[J]. Nat Rev Microbiol, 2022, 20(2):95-108. |
[2]
|
中华医学会妇科肿瘤学分会,中国优生科学协会阴道镜和宫颈病理学分会.人乳头瘤病毒疫苗临床应用中国专家共识[J].协和医学杂志, 2021, 12:13. |
[3]
|
EBERHARDT C S, KISSICK H T, PATEL M R, et al. Functional HPV-specific PD-1(+) stem-like CD8 T cells in head and neck cancer[J]. Nature, 2021, 597(7875):279-84. |
[4]
|
MANGA S M, YE Y, NULAH K L, et al. Human Papillomavirus Types and Cervical Cancer Screening among Female Sex Workers in Cameroon[J]. Cancers (Basel), 2024, 16(2). |
[5]
|
CHEN L, DONG Y, LI J, et al. The genomic distribution map of human papillomavirus in Western China[J]. Epidemiol Infect, 2021, 149:e135. |
[6]
|
ZENG Z, AUSTIN R M, WANG L, et al. Nationwide Prevalence and Genotype Distribution of HighRisk Human Papillomavirus Infection in China[J]. Am J Clin Pathol, 2022, 157(5):718-23. |
[7]
|
ZHANG J, CHENG K, WANG Z. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China:a meta-analysis[J]. Arch Gynecol Obstet, 2020, 302(6):1329-37. |
[8]
|
LIU L, WANG D, DONG H, et al. Characteristics of carcinogenic HPV genotypes in North China Plain and the association with cervical lesions[J]. Medicine (Baltimore), 2019, 98(37):e17087. |
[9]
|
MA M, ZHU J, YANG Y, et al. The distribution and pathogenic risk of non-9-valent vaccine covered HPV subtypes in cervical lesions[J]. Cancer Med, 2022, 11(6):1542-52. |
[10]
|
HARDEN M E, MUNGER K. Human papillomavirus molecular biology[J]. Mutat Res Rev Mutat Res, 2017, 772:3-12. |
[11]
|
DELLA FERA A N, WARBURTON A, COURSEY T L, et al. Persistent Human Papillomavirus Infection[J]. Viruses, 2021, 13(2). |
[12]
|
MCBRIDE A A. Mechanisms and strategies of papillomavirus replication[J]. Biol Chem, 2017, 398(8):919-27. |
[13]
|
BERNARD H U. Regulatory elements in the viral genome[J]. Virology, 2013, 445(1-2):197-204. |
[14]
|
LETUNIC I, BORK P. Interactive Tree Of Life (iTOL) v5:an online tool for phylogenetic tree display and annotation[J]. Nucleic Acids Research, 2021, 49(W1):W293-W6. |
[15]
|
吴玉章,朱锡华.一种病毒蛋白B细胞表位预测方法的建立[J].科学通报, 1994,(24):2275-9. |
[16]
|
HE J, YANG Y, CHEN Z, et al. Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China[J]. Virol J, 2019, 16(1):72. |
[17]
|
BURK R D, HARARI A, CHEN Z. Human papillomavirus genome variants[J]. Virology, 2013, 445(1-2):232-43. |
[18]
|
CHEN Z, SCHIFFMAN M, HERRERO R, et al. Evolution and taxonomic classification of human papillomavirus 16(HPV16)-related variant genomes:HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67[J]. PLoS One, 2011, 6(5):e20183. |
[19]
|
SUNG H, FERLAY J, SIEGEL R L, et al. Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3):209-49. |
[20]
|
Estimated numbers (incidence and mortality) of cancer of cervix uteri from 2020 to 2040, females, age[0-85+], China[Z]. https://gco.iarc.fr/tomorrow/en/dataviz/trends?sexes=2&cancers=23&populations=160; International Agency for Research on Cancer (IARC). 2023 |
[21]
|
CAO M, CHENZHANG Y, DING X, et al. Genetic variability and lineage phylogeny of human papillomavirus type-16 and-53 based on the E6, E7, and L1 genes in Southwest China[J]. Gene, 2016, 592(1):49-59. |
[22]
|
MARIZ F C, PUTZKER K, SEHR P, et al. Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2[J]. Front Immunol, 2023, 14:1272018. |
[23]
|
OLCZAK P, RODEN R B S. Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases[J]. Vaccines (Basel), 2020, 8(4). |
[24]
|
KADAJA M, ISOK-PAAS H, LAOS T, et al. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses[J]. PLoS Pathog, 2009, 5(4):e1000397. |
[25]
|
DOORBAR J. The E4 protein; structure, function and patterns of expression[J]. Virology, 2013, 445(1-2):80-98. |
[26]
|
BRAVO I G, ALONSO A. Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth[J]. J Virol, 2004, 78(24):13613-26. |
[27]
|
SCHIFFMAN M, HERRERO R, DESALLE R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution[J]. Virology, 2005, 337(1):76-84. |
[28]
|
MCINNIS C, BHATIA S, VIJAYKUMAR B, et al. Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment[J]. J Immunother Cancer, 2023, 11(3). |